COVID-19 Impact on the Global Medical Ceramics Market
The global spread of COVID-19 has led to the complete suspension of elective surgeries, especially in the
most-affected countries. Some regions witnessed a 70% reduction in the number of patients seeking
aesthetic treatments from January 2020 onwards. Moreover, several dental events have been
postponed due to the COVID-19 pandemic. For instance, KRAKDENT 2020, the largest dental show in
Poland and an event that attracts over 15,000 visitors worldwide, have been rescheduled. The CEO of
Straumann Group announced that the COVID-19 outbreak was expected to reduce sales in the Asia
Pacific in FY 2020 by at least USD 31 million. Additionally, DENTSPLY Sirona recently predicted that its
sales in the Chinese, South Korean, Taiwanese, and Japanese markets would fall by a cumulative USD
60–70 million in FY 2020.
Request a Sample Pages:
Increasing research activities for the development of novel medical ceramics, growing demand for
medical ceramics in plastic surgeries & wound healing applications; the rising number of hip & knee
replacement procedures; and the increasing demand for implantable devices are responsible for the
significant growth of the electrophysiology market during the review period.
[ 187 Pages Report] The global medical ceramics market is projected to reach USD 12.9 billion by 2025
from USD 9.6 billion in 2020, growing at a CAGR of 5.9% from 2020 to 2025.
“Hydroxyapatite: The largest segment of bioactive ceramics market”
Based on type, the global bioactive ceramics market is segmented into hydroxyapatite and glass
ceramics. In 2019, the hydroxyapatite segment accounted for the largest share of the global bioactive
ceramics market. This segment is also expected to grow at the highest rate during the forecast period.
Hydroxyapatite has high biocompatibility, bioactivity, and osteoconductivity; making it suitable for a
wide range of applications, such as a